600867 通化东宝
已收盘 08-26 15:00:00
资讯
新帖
简况
研报掘金丨平安证券：维持通化东宝“推荐”评级，国际化战略多点突破
格隆汇 · 08-26 15:19
研报掘金丨平安证券：维持通化东宝“推荐”评级，国际化战略多点突破
股市必读：通化东宝中报 - 第二季度单季净利润同比增长59.07%
证券之星 · 08-26 04:36
股市必读：通化东宝中报 - 第二季度单季净利润同比增长59.07%
图解通化东宝中报：第二季度单季净利润同比增长59.07%
证券之星 · 08-25 01:15
图解通化东宝中报：第二季度单季净利润同比增长59.07%
通化东宝（600867）披露2026年半年度报告，8月24日股价下跌1.97%
证券之星 · 08-24 22:21
通化东宝（600867）披露2026年半年度报告，8月24日股价下跌1.97%
通化东宝：公司将于9月3日召开2026年半年度业绩说明会
证券日报网 · 08-24 21:31
通化东宝：公司将于9月3日召开2026年半年度业绩说明会
通化东宝最新公告：决定终止THDBH110/THDBH110胶囊研发项目并计提资产减值准备
证券之星 · 08-24 18:12
通化东宝最新公告：决定终止THDBH110/THDBH110胶囊研发项目并计提资产减值准备
每周股票复盘：通化东宝（600867）东宝集团累计质押5.82亿股
证券之星 · 08-16
每周股票复盘：通化东宝（600867）东宝集团累计质押5.82亿股
股市必读：通化东宝新发布《通化东宝关于控股股东股份解押及再质押公告》
证券之星 · 08-13
股市必读：通化东宝新发布《通化东宝关于控股股东股份解押及再质押公告》
通化东宝：胰岛素西林瓶生产线项目目前处于建设推进阶段
证券之星 · 08-12
通化东宝：胰岛素西林瓶生产线项目目前处于建设推进阶段
通化东宝（600867）披露参与认购特宝生物可转债结果，8月11日股价上涨0.84%
证券之星 · 08-11
通化东宝（600867）披露参与认购特宝生物可转债结果，8月11日股价上涨0.84%
通化东宝（600867）股东东宝实业集团股份有限公司质押1900万股，占总股本0.97%
证券之星 · 08-11
通化东宝（600867）股东东宝实业集团股份有限公司质押1900万股，占总股本0.97%
通化东宝：甘精胰岛素BLA已正式向美国 FDA 递交
证券之星 · 08-11
通化东宝：甘精胰岛素BLA已正式向美国 FDA 递交
通化东宝：1.62亿元认购特宝生物可转债获配售将上市
格隆汇 · 08-11
通化东宝：1.62亿元认购特宝生物可转债获配售将上市
股市必读：通化东宝（600867）8月6日董秘有最新回复
证券之星 · 08-07
股市必读：通化东宝（600867）8月6日董秘有最新回复
通化东宝：2026年第一季度加权平均净资产收益率为1.77%
证券之星 · 08-06
通化东宝：2026年第一季度加权平均净资产收益率为1.77%
通化东宝：公司将继续通过提升经营质量、推进产品放量和创新研发，努力提升长期回报能力
证券之星 · 08-06
通化东宝：公司将继续通过提升经营质量、推进产品放量和创新研发，努力提升长期回报能力
每周股票复盘：通化东宝（600867）门冬胰岛素获FDA上市批准
证券之星 · 08-02
每周股票复盘：通化东宝（600867）门冬胰岛素获FDA上市批准
通化东宝（600867）披露控股股东股份解押及再质押公告，7月28日股价上涨2.48%
证券之星 · 07-28
通化东宝（600867）披露控股股东股份解押及再质押公告，7月28日股价上涨2.48%
通化东宝最新公告：门冬胰岛素注射液获美国FDA上市批准
证券之星 · 07-27
通化东宝最新公告：门冬胰岛素注射液获美国FDA上市批准
通化东宝(600867.SH)拟认购特宝生物可转债不超1.62亿元
智通财经 · 07-27
通化东宝(600867.SH)拟认购特宝生物可转债不超1.62亿元
加载更多
公司概况
公司名称：
通化东宝药业股份有限公司
所属行业：
医药制造业
上市日期：
1994-08-24
主营业务：
通化东宝药业股份有限公司的主营业务是糖尿病及内分泌治疗领域生物制品、中成药、化学药等药品的研发、生产和销售。公司的主要产品是人胰岛素原料药、人胰岛素注射剂（注册商标：甘舒霖）、甘精胰岛素原料药、甘精胰岛素注射液（注册商标：平舒霖）、门冬胰岛素原料药、门冬胰岛素注射液、预混型门冬胰岛素（门冬胰岛素30注射液与门冬胰岛素50注射液）（注册商标：锐舒霖）、利拉鲁肽注射液（注册商标：统博力）、恩格列净片（注册商标：唐捷恩）、镇脑宁胶囊、糖尿病相关的医疗器械等。
发行价格：
6.50
{"stockData":{"symbol":"600867","market":"SH","secType":"STK","nameCN":"通化东宝","latestPrice":8.12,"timestamp":1787727601000,"preClose":8.1,"halted":0,"volume":25317576,"delay":0,"changeRate":0.0025,"floatShares":1959000000,"shares":1959000000,"eps":0.6623,"marketStatus":"已收盘","change":0.02,"latestTime":"08-26 15:00:00","open":8.1,"high":8.27,"low":8.1,"amount":207000000,"amplitude":0.021,"askPrice":8.13,"askSize":447,"bidPrice":8.12,"bidSize":1712,"shortable":0,"etf":0,"ttmEps":0.6623,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787794200000},"marketStatusCode":5,"adr":0,"adjPreClose":8.1,"symbolType":"stock","openAndCloseTimeList":[[1787707800000,1787715000000],[1787720400000,1787727600000]],"highLimit":8.91,"lowLimit":7.29,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1958542829,"isCdr":false,"pbRate":2.33,"roa":"--","peRate":12.260305,"roe":"4.07%","epsLYR":0.62,"committee":0.553565,"marketValue":15903000000,"turnoverRate":0.0129,"status":0,"floatMarketCap":15903000000},"requestUrl":"/m/hq/s/600867/","defaultTab":"news","newsList":[{"id":"2662350793","title":"研报掘金丨平安证券：维持通化东宝“推荐”评级，国际化战略多点突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2662350793","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662350793?lang=zh_cn&edition=full","pubTime":"2026-08-26 15:19","pubTimestamp":1787728763,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["600867","BK0188","BK0239","161027","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662526647","title":"股市必读：通化东宝中报 - 第二季度单季净利润同比增长59.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662526647","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662526647?lang=zh_cn&edition=full","pubTime":"2026-08-26 04:36","pubTimestamp":1787690174,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，通化东宝报收于8.1元，上涨1.89%，换手率1.34%，成交量26.24万手，成交额2.14亿元。业绩披露要点：2026年第二季度归母净利润1.69亿元，同比增长59.07%。公司公告汇总：董事会审议通过终止THDBH110/THDBH110胶囊研发项目，并对资本化金额1,688.54万元全额计提资产减值准备。股本股东变化股东户数变动截至2026年6月30日公司股东户数为11.47万户，较3月31日增加1.15万户，增幅为11.19%；户均持股数量由1.9万股减少至1.71万股，户均持股市值为13.73万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600008052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208113","title":"图解通化东宝中报：第二季度单季净利润同比增长59.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208113","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662208113?lang=zh_cn&edition=full","pubTime":"2026-08-25 01:15","pubTimestamp":1787591727,"startTime":"0","endTime":"0","summary":"证券之星消息，通化东宝2026年中报显示，上半年度公司主营收入15.53亿元，同比上升11.13%；归母净利润2.96亿元，同比上升37.32%；扣非净利润2.96亿元，同比上升35.55%；其中2026年第二季度，公司单季度主营收入8.05亿元，同比上升7.96%；单季度归母净利润1.69亿元，同比上升59.07%；单季度扣非净利润1.69亿元，同比上升55.67%；负债率12.95%，投资收益3672.16万元，财务费用486.95万元，毛利率70.79%。财报数据概要请见下图:本文数据来源于通化东宝2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500003433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272892","title":"通化东宝（600867）披露2026年半年度报告，8月24日股价下跌1.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272892","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661272892?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:21","pubTimestamp":1787581300,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，通化东宝报收于7.95元，较前一交易日下跌1.97%，最新总市值为155.7亿元。该股当日开盘8.1元，最高8.13元，最低7.9元，成交额达2.24亿元，换手率为1.43%。近日，通化东宝药业股份有限公司披露2026年半年度报告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400037261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","600867","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661790272","title":"通化东宝：公司将于9月3日召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2661790272","media":"证券日报网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661790272?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:31","pubTimestamp":1787578260,"startTime":"0","endTime":"0","summary":"证券日报网讯8月24日，通化东宝发布公告称，公司2026年半年度业绩说明会定于2026年9月3日14：00-15：00召开。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-24/doc-inipmsvn5998108.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-24/doc-inipmsvn5998108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600867","BK0196","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220980","title":"通化东宝最新公告：决定终止THDBH110/THDBH110胶囊研发项目并计提资产减值准备","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661220980?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:12","pubTimestamp":1787566344,"startTime":"0","endTime":"0","summary":"通化东宝(600867.SH)公告称，公司决定终止THDBH110/THDBH110胶囊研发项目，并对该项目研发资本化金额全额计提资产减值准备，合计1688.54万元，将减少2026年半年度利润总额1688.54万元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400025929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867","BK0196","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659175404","title":"每周股票复盘：通化东宝（600867）东宝集团累计质押5.82亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2659175404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659175404?lang=zh_cn&edition=full","pubTime":"2026-08-16 01:57","pubTimestamp":1786816630,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，通化东宝报收于8.57元，较上周的8.42元上涨1.78%。本周，通化东宝8月11日盘中最高价报8.82元。本次解押及再质押后，东宝集团累计质押股份581,939,472股，占其所持公司股份的93.94%，占公司总股本的29.71%。通化东宝药业股份有限公司控股股东东宝集团于2026年8月11日解除质押32,000,000股，并同日将相同数量股份重新质押给交通银行股份有限公司通化分行，用于补充流动资金。东宝集团及其一致行动人合计质押股份占其所持股份总额的90.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600867","BK0196","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659390117","title":"股市必读：通化东宝新发布《通化东宝关于控股股东股份解押及再质押公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659390117","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659390117?lang=zh_cn&edition=full","pubTime":"2026-08-13 01:05","pubTimestamp":1786554315,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘，通化东宝报收于8.39元，下跌0.71%，换手率1.48%，成交量28.92万手，成交额2.45亿元。公司公告汇总：控股股东东宝集团于8月10日、8月11日分别完成两笔各1900万股、3200万股的股份解押及再质押，累计质押股份数维持581,939,472股，占其所持股份93.94%、占公司总股本29.71%。公司公告汇总：通化东宝以16,204.20万元认购特宝生物可转债1,620,420张，该债券将于8月13日在上交所上市，公司承诺六个月内不减持。公告明确本次质押不影响公司生产经营和控制权稳定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300000892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0196","600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658922954","title":"通化东宝：胰岛素西林瓶生产线项目目前处于建设推进阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2658922954","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658922954?lang=zh_cn&edition=full","pubTime":"2026-08-12 15:33","pubTimestamp":1786520001,"startTime":"0","endTime":"0","summary":"证券之星消息，通化东宝(600867)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好！看到“通化县发布”8月8日新闻，提及贵司“西林瓶项目”建设，我想了解项目建设缘由、建设规模、建设进度等方面的情况，希望回复，谢谢！通化东宝回复：感谢您对公司的关注。公司胰岛素西林瓶生产线项目目前处于建设推进阶段，设计产能为 4,000 万支。该项目主要用于扩大公司制剂灌装能力，匹配快速增长的海外出口订单增量需求，是公司国际化产能布局的重要组成部分。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200021013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","600867","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916091","title":"通化东宝（600867）披露参与认购特宝生物可转债结果，8月11日股价上涨0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916091","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658916091?lang=zh_cn&edition=full","pubTime":"2026-08-11 22:20","pubTimestamp":1786458029,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，通化东宝报收于8.45元，较前一交易日上涨0.84%，最新总市值为165.5亿元。该股当日开盘8.37元，最高8.82元，最低8.36元，成交额达4.22亿元，换手率为2.52%。近日，通化东宝发布《关于行使优先配售权参与认购厦门特宝生物工程股份有限公司向不特定对象发行可转换公司债券的结果公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100038349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","688278","600867","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658673991","title":"通化东宝（600867）股东东宝实业集团股份有限公司质押1900万股，占总股本0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658673991","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658673991?lang=zh_cn&edition=full","pubTime":"2026-08-11 18:22","pubTimestamp":1786443748,"startTime":"0","endTime":"0","summary":"证券之星消息，通化东宝8月11日公开信息显示，股东东宝实业集团股份有限公司向中国农业银行股份有限公司通化县支行合计质押1900.0万股，占总股本0.97%。质押详情见下表：截止本公告日，股东东宝实业集团股份有限公司已累计质押股份5.82亿股，占其持股总数的93.94%。通化东宝主营业务：药品研发、生产和销售,主要业务涵盖生物制品、中成药、化学药,治疗领域以糖尿病及内分泌、心脑血管为主。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100031710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867","BK0239","BK0196","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995604","title":"通化东宝：甘精胰岛素BLA已正式向美国 FDA 递交","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995604","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658995604?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:54","pubTimestamp":1786438457,"startTime":"0","endTime":"0","summary":"证券之星消息，通化东宝(600867)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好！最近看到健友股份美国子公司发布的消息，贵司甘精胰岛素BLA已经递交FDA评审，烦介绍详细情况。谢谢！通化东宝回复：感谢您对公司的关注。甘精胰岛素BLA已正式向美国 FDA 递交。甘精胰岛素注射液系公司与健友股份合作开发的三款美国市场胰岛素产品之一（门冬、甘精、赖脯），其中门冬胰岛素已获得美国 FDA 批准上市，是首个获美国 FDA 上市许可的国产门冬胰岛素注射液。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100026607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867","BK0196","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658960092","title":"通化东宝：1.62亿元认购特宝生物可转债获配售将上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2658960092","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658960092?lang=zh_cn&edition=full","pubTime":"2026-08-11 15:40","pubTimestamp":1786434059,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["600867","BK0196","BK0239","688278","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657651005","title":"股市必读：通化东宝（600867）8月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657651005","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657651005?lang=zh_cn&edition=full","pubTime":"2026-08-07 02:32","pubTimestamp":1786041133,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，通化东宝报收于8.11元，下跌1.82%，换手率1.21%，成交量23.62万手，成交额1.92亿元。董秘最新回复投资者： 董秘你好！后续如有新的回购注销计划，公司将严格按照规定履行信息披露义务。同期，公司营业收入同比增长 14.76%，归属于上市公司股东的净利润同比增长 16.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700002194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867","BK0188","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657689534","title":"通化东宝：2026年第一季度加权平均净资产收益率为1.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657689534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657689534?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:03","pubTimestamp":1786006993,"startTime":"0","endTime":"0","summary":"证券之星消息，通化东宝08月06日在投资者关系平台上答复投资者关心的问题。请问，为啥今年一季度，贵公司净资产收益率 大幅下降?公司2026年第一季度加权平均净资产收益率为 1.77%，上年同期为 1.70%，同比增加 0.07 个百分点，您提到的净资产收益率下降可能存在误解，实际实现同比提升。同期，公司营业收入同比增长 14.76%，归属于上市公司股东的净利润同比增长 16.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600027864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867","BK0196","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657689551","title":"通化东宝：公司将继续通过提升经营质量、推进产品放量和创新研发，努力提升长期回报能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2657689551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657689551?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:03","pubTimestamp":1786006987,"startTime":"0","endTime":"0","summary":"证券之星消息，通化东宝(600867)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司股票价格跌跌不休，市值不断缩水，贵公司近期有没有股票回购注销计划维护市值稳定通化东宝回复：感谢您对公司的关注。公司始终将股东回报置于重要位置，并持续通过股份回购、员工持股计划/股权激励、现金分红等多种方式积极回报投资者与维护公司价值。公司将继续通过提升经营质量、推进产品放量和创新研发，努力提升长期回报能力。后续如有新的回购注销计划，公司将严格按照规定履行信息披露义务。我们会将您的建议转达公司管理层。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600027860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0196","600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656031969","title":"每周股票复盘：通化东宝（600867）门冬胰岛素获FDA上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2656031969","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656031969?lang=zh_cn&edition=full","pubTime":"2026-08-02 03:19","pubTimestamp":1785611949,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，通化东宝报收于8.37元，较上周的7.79元上涨7.45%。本周，通化东宝7月29日盘中最高价报8.47元。本周关注点公司公告汇总：门冬胰岛素注射液获美国FDA上市批准。该药品名为Garzulys，适用于改善成人及儿科糖尿病患者的血糖控制。东宝集团及其一致行动人合计持有公司股份641,362,975股，占公司总股本的32.75%，累计质押股份占其所持股份的90.73%。公告披露了东宝集团财务状况、偿债能力及质押风险应对措施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200001058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","600867","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654888730","title":"通化东宝（600867）披露控股股东股份解押及再质押公告，7月28日股价上涨2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654888730","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654888730?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:17","pubTimestamp":1785248236,"startTime":"0","endTime":"0","summary":"近日，通化东宝药业股份有限公司发布《关于控股股东股份解押及再质押公告》。公告显示，公司控股股东东宝集团于2026年7月27日解除质押给中国建设银行股份有限公司通化分行的33,000,000股股份，并同日将相同数量股份重新质押给该行，用于偿还债务。本次解押及再质押后，东宝集团累计质押股份581,939,472股，占其所持公司股份的93.94%，占公司总股本的29.71%。公告披露了东宝集团财务状况、偿债能力及质押风险应对措施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800039774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600867","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654168600","title":"通化东宝最新公告：门冬胰岛素注射液获美国FDA上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2654168600","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654168600?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:24","pubTimestamp":1785144259,"startTime":"0","endTime":"0","summary":"通化东宝(600867.SH)公告称，公司与健友股份合作开发的门冬胰岛素注射液正式获得美国食品药品监督管理局(FDA)上市批准，用于改善成人及儿科糖尿病患者的血糖控制。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700022317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","BK0239","600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654183470","title":"通化东宝(600867.SH)拟认购特宝生物可转债不超1.62亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2654183470","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654183470?lang=zh_cn&edition=full","pubTime":"2026-07-27 16:01","pubTimestamp":1785139282,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 通化东宝(600867.SH)发布公告，公司参股公司厦门特宝生物工程股份有限公司(证券简称：特宝生物，证券代码：688278)向不特定对象发行可转换公司债券，募集资金总额不超过人民币15.33亿元。公司计划行使优先配售权参与认购特宝生物可转债。本次计划参与认购特宝生物可转债的投资本金不超过1.62亿元人民币。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SABA","BK0188","FCEF","BK0196","688278","BK0239","600867"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787765991432,"stockEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":0.0087},{"period":"3month","weight":0.0349},{"period":"6month","weight":-0.0618},{"period":"1year","weight":-0.0328},{"period":"ytd","weight":0.0311}],"compareEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0141},{"period":"3month","weight":-0.0454},{"period":"6month","weight":-0.0601},{"period":"1year","weight":0.0114},{"period":"ytd","weight":-0.0142}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"通化东宝药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"114726人(较上一季度增加11.19%)","perCapita":"17071股","listingDate":"1994-08-24","address":"吉林省通化市通化县东宝新村","registeredCapital":"195854万元","survey":" 通化东宝药业股份有限公司的主营业务是糖尿病及内分泌治疗领域生物制品、中成药、化学药等药品的研发、生产和销售。公司的主要产品是人胰岛素原料药、人胰岛素注射剂（注册商标：甘舒霖）、甘精胰岛素原料药、甘精胰岛素注射液（注册商标：平舒霖）、门冬胰岛素原料药、门冬胰岛素注射液、预混型门冬胰岛素（门冬胰岛素30注射液与门冬胰岛素50注射液）（注册商标：锐舒霖）、利拉鲁肽注射液（注册商标：统博力）、恩格列净片（注册商标：唐捷恩）、镇脑宁胶囊、糖尿病相关的医疗器械等。","listedPrice":6.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通化东宝(600867)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通化东宝(600867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通化东宝,600867,通化东宝股票,通化东宝股票老虎,通化东宝股票老虎国际,通化东宝行情,通化东宝股票行情,通化东宝股价,通化东宝股市,通化东宝股票价格,通化东宝股票交易,通化东宝股票购买,通化东宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通化东宝(600867)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通化东宝(600867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}